SAB Biotherapeutics reports Q1 2026 results, enrollment progress
Go back to SAB Biotherapeutics reports Q1 2026 results, enrollment progress| (NASDAQ: SABS) | Delayed: 3.50 -0.08 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $ | |||
| Open | $3.59 | 52 Week Low | $ | |||
| Day High | $3.62 | P/E | N/A | |||
| Day Low | $3.49 | EPS | $ | |||
| Volume | 736,401 | |||||
| (NASDAQ: SABSW) | Delayed: 0.01 -0.01 (50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 9,697 | |||||
